TD Cowen initiated coverage on Honeywell Aerospace (HONA) with a Hold rating and a $250 price target, citing subdued profit leverage compared to other aerospace peers. The firm anticipates less than 10% adjusted operating profit growth through 2026-27 due to minimal margin expansion and limited room for aggressive capital returns post-spin-off from Honeywell International (HON). Despite this, HONA is expected to join the S&P 500 and S&P 100 on Monday, while RBC had a more positive outlook with a Buy rating and a $300 price target.

T-Mobile US, Inc. (NASDAQ:TMUS) has received a "Moderate Buy" consensus rating from 30 brokerages, with an average 1-year target price of $260.27. The company's recent quarterly results surpassed expectations with an EPS of $2.27 and a 10.6% year-over-year revenue increase, leading to a declared quarterly dividend of $1.02 per share. Insider activity includes both a significant purchase by Andre Almeida and a sale by Jon Freier, while institutional investors have adjusted their holdings.

EPAM Systems, Inc. has been recognized as a top IT services provider in the UK and Ireland by Whitelane Research, achieving #1 rankings for general satisfaction, application services, and service delivery quality. The report, based on feedback from nearly 400 senior IT decision makers, highlighted EPAM's strong client satisfaction score of 85% and its leading track record in using AI technology for service improvement. This recognition underscores EPAM's focus on helping clients achieve AI-enabled transformation and deliver measurable business outcomes.

Allegro MicroSystems, Inc. (NasdaqGS: ALGM) has been added to the Russell 1000 Growth Benchmark. The company specializes in designing and developing sensor integrated circuits and application-specific power ICs, serving primarily the automotive and industrial markets. This inclusion highlights Allegro MicroSystems' growth trajectory and market recognition.

Brokerages have issued a consensus "Reduce" rating for Illinois Tool Works (NYSE:ITW), with an average 12-month price target of $271.92. This caution comes despite the company beating recent earnings expectations with $2.66 EPS and $4.02 billion in revenue, and reaffirming its FY 2026 EPS guidance. Illinois Tool Works also declared a quarterly dividend of $1.61 per share.

BT Group and Verizon Communications Inc. have signed an agreement to combine their international enterprise operations into a 50:50 joint venture. This new entity will focus on providing international connectivity services to over 3,000 multinational customers across more than 180 countries, representing approximately $4 billion in combined annual revenue. Martijn Blanken has been appointed CEO-designate, and the transaction is expected to be completed in 2027, subject to regulatory clearances.

Goldman Sachs and Morgan Stanley bankers might face a less busy summer than anticipated due to potential delays in major tech IPOs, exemplified by OpenAI considering postponing its offering. This postponement, along with concerns about the tech sector's capital expenditure and a potential shift to a risk-off market, could impact bankers' revenues despite strong H1 performance. Additionally, the consulting industry is grappling with new pricing models necessitated by AI and automation, moving away from traditional billable hours towards project-based fees.

Norwegian Cruise Line Holdings Ltd. (NCLH) has been removed from the Russell 1000 Growth Benchmark, as reported by S&P Capital IQ. This news follows a similar announcement about its removal from the Russell 3000E Growth Benchmark. The company's stock shows a 5-day change of +1.24% and a year-to-date change of +3.91%.

Tactile Systems Technology, Inc. (NasdaqGM:TCMD) has been added to the Russell 3000E Growth Benchmark. This inclusion signifies the company's growth trajectory and could increase its visibility among investors. The medical technology company specializes in devices for chronic diseases like lymphedema and chronic respiratory conditions.

Wall Street Zen downgraded CVS Health (NYSE:CVS) from a "buy" to a "hold" rating, though the general analyst consensus remains a "Moderate Buy" with an average price target of $101.28. Despite this downgrade, several other firms have recently raised their price targets for CVS. The company reported strong Q1 results, exceeding both earnings and revenue expectations, but also saw significant insider share sales.